TreatHF

TreatHF helps clinicians confirm which therapies are suggested for their patients with symptomatic heart failure and provides guidance on the use of each therapy.

Enter patient indications
Review individualized next steps for medical therapy
Email or print a summary of the next steps
Reference detailed information on
- Initiation, titration, and monitoring of each medication
- Guidance for optimizing your overall medication strategy

What's new in the 2025 app update:

Expanded to include HFpEF and HFmrEF clinical guidance, including the H₂FpEF diagnostic system
Updated with content from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, the 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction, and the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction, including information regarding use of oral soluble guanylyl cyclase stimulators (Vericiguat)
Updated app structure for improved user experience
Updated and expanded Therapy Reference section

Information in this app is derived from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, the 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction, and the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction. Indications collected in the app reflect the evidence-based indications outlined in these documents and are meant to serve as a starting point. They do not represent the full list of considerations for prescribing and optimizing a medication or other clinical therapy. Use of this app assumes clinicians will conduct a full evaluation of the patient, consult relevant medical specialists as needed, utilize a team-based approach to optimize therapy. In addition, therapeutic options should be determined after discussion between the patient and their care provider. Use of this app is meant to support clinical decisions. It does not represent the only or best course of care or replace clinical judgment.

TreatHF was developed as part of an ongoing effort at the ACC to facilitate access and implementation of ACC clinical policy at the point of care. This app was created with support by Bayer with no input on content.